Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-05-17 Sale |
2023-05-18 5:12 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $88.66 | $110,825 | 786,870 (Indirect Direct) |
View |
2023-05-16 Sale |
2023-05-18 5:10 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
30,000 | $85.66 | $2,569,900 | 2,466,223 (Indirect Direct) |
View |
2023-05-08 Sale |
2023-05-09 5:02 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
12,000 | $92.39 | $1,108,680 | 1,143,807 (Direct) |
View |
2023-05-03 Sale |
2023-05-04 4:40 pm |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $82.71 | $413,550 | 358,495 (Direct) |
View |
2023-04-18 Sale |
2023-04-20 4:51 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
30,000 | $82.02 | $2,460,720 | 2,546,223 (Indirect Direct) |
View |
2023-04-17 Sale |
2023-04-18 4:30 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $81.05 | $101,313 | 788,120 (Indirect Direct) |
View |
2023-04-10 Sale |
2023-04-11 4:20 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
12,000 | $78.21 | $938,520 | 1,155,807 (Direct) |
View |
2023-04-03 Sale |
2023-04-05 4:54 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
500 | $74.05 | $37,025 | 403,831 (Indirect Direct) |
View |
2023-04-03 Sale |
2023-04-05 4:52 pm |
Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer |
5,000 | $75 | $375,000 | 152,430 (Direct) |
View |
2023-04-03 Sale |
2023-04-05 4:50 pm |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $74.05 | $370,250 | 363,495 (Direct) |
View |
2023-03-21 Sale |
2023-03-23 4:55 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
30,000 | $62.74 | $1,882,332 | 2,958,842 (Indirect Direct) |
View |
2023-03-17 Sale |
2023-03-21 4:35 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $64.03 | $80,038 | 789,370 (Indirect Direct) |
View |
2023-03-08 Sale |
2023-03-10 5:18 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
12,000 | $63.79 | $765,480 | 1,167,807 (Direct) |
View |
2023-03-03 Sale |
2023-03-07 4:53 pm |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $63.84 | $319,200 | 368,495 (Direct) |
View |
2023-03-01 Sale |
2023-03-02 4:20 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
500 | $65.33 | $32,665 | 404,331 (Indirect Direct) |
View |
2023-02-23 Sale |
2023-02-27 4:34 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
1,646 | $68.76 | $113,179 | 53,883 (Direct) |
View |
2023-02-23 Sale |
2023-02-27 4:32 pm |
Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer |
1,104 | $68.76 | $75,911 | 41,430 (Direct) |
View |
2023-02-17 Sale |
2023-02-21 4:22 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $52.38 | $65,475 | 790,620 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-05-24 Gift |
2023-05-25 4:44 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
20,000 | $0 | 1,846,223 (Direct) |
View |
2023-05-17 Exercise |
2023-05-18 5:12 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $0 | 786,870 (Direct) |
View |
2023-05-17 Exercise |
2023-05-18 5:12 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $2.67 | 786,870 (Direct) |
View |
2023-05-16 Exercise |
2023-05-18 5:10 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
50,000 | $0 | 2,466,223 (Direct) |
View |
2023-05-16 Exercise |
2023-05-18 5:10 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
50,000 | $2.67 | 2,466,223 (Direct) |
View |
2023-05-08 Exercise |
2023-05-09 5:02 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $0 | 1,143,807 (Direct) |
View |
2023-05-08 Exercise |
2023-05-09 5:02 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $2.67 | 1,143,807 (Direct) |
View |
2023-05-03 Exercise |
2023-05-04 4:40 pm |
N/A 2028-11-15 |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $0 | 358,495 (Direct) |
View |
2023-05-03 Exercise |
2023-05-04 4:40 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $15.09 | 358,495 (Direct) |
View |
2023-05-03 Gift |
2023-05-03 4:22 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
20,000 | $0 | 133,945 (Direct) |
View |
2023-04-27 Gift |
2023-04-28 4:15 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
382,946 | $0 | 1,826,223 (Direct) |
View |
2023-04-21 Gift |
2023-04-24 4:20 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
67,955 | $0 | 184,968 (Direct) |
View |
2023-04-18 Exercise |
2023-04-20 4:51 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
50,000 | $0 | 2,546,223 (Direct) |
View |
2023-04-18 Exercise |
2023-04-20 4:51 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
50,000 | $2.67 | 2,546,223 (Direct) |
View |
2023-04-19 Gift |
2023-04-20 4:15 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
36,232 | $0 | 133,945 (Direct) |
View |
2023-04-17 Exercise |
2023-04-18 4:30 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $0 | 788,120 (Direct) |
View |
2023-04-17 Exercise |
2023-04-18 4:30 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $2.67 | 788,120 (Direct) |
View |
2023-04-10 Exercise |
2023-04-11 4:20 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $0 | 1,155,807 (Direct) |
View |
2023-04-10 Exercise |
2023-04-11 4:20 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $2.67 | 1,155,807 (Direct) |
View |
2023-04-03 Gift |
2023-04-05 5:56 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
634,211 | $0 | 1,806,223 (Direct) |
View |
2023-04-03 Exercise |
2023-04-05 4:52 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer |
5,000 | $34.11 | 152,430 (Direct) |
View |
2023-04-03 Exercise |
2023-04-05 4:52 pm |
N/A 2030-05-03 |
Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer |
5,000 | $0 | 152,430 (Direct) |
View |
2023-04-03 Exercise |
2023-04-05 4:50 pm |
N/A 2028-11-15 |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $0 | 363,495 (Direct) |
View |
2023-04-03 Exercise |
2023-04-05 4:50 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $15.09 | 363,495 (Direct) |
View |
2023-03-22 Exercise |
2023-03-23 4:55 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
7,221 | $13.85 | 2,958,842 (Direct) |
View |
2023-03-21 Exercise |
2023-03-23 4:55 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
157,221 | $0 | 2,958,842 (Direct) |
View |
2023-03-21 Exercise |
2023-03-23 4:55 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
50,000 | $2.67 | 2,958,842 (Direct) |
View |
2023-03-22 Exercise |
2023-03-23 4:55 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
100,000 | $3.76 | 2,958,842 (Direct) |
View |
2023-03-17 Exercise |
2023-03-21 4:35 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $0 | 789,370 (Direct) |
View |
2023-03-17 Exercise |
2023-03-21 4:35 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $2.67 | 789,370 (Direct) |
View |
2023-03-08 Exercise |
2023-03-10 5:18 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $0 | 1,167,807 (Direct) |
View |
2023-03-08 Exercise |
2023-03-10 5:18 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $2.67 | 1,167,807 (Direct) |
View |
2023-03-03 Exercise |
2023-03-07 4:53 pm |
N/A 2028-11-15 |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $0 | 368,495 (Direct) |
View |
2023-03-03 Exercise |
2023-03-07 4:53 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $15.09 | 368,495 (Direct) |
View |
2023-02-27 Exercise |
2023-03-01 4:10 pm |
N/A 2026-02-06 |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
100,000 | $0 | 1,837,842 (Direct) |
View |
2023-02-27 Exercise |
2023-03-01 4:10 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
100,000 | $3.76 | 1,837,842 (Direct) |
View |
2023-02-21 Tax Withholding |
2023-02-22 06:50 am |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer |
553 | $58.5 | 51,936 (Direct) |
View |
2023-02-21 Option Award |
2023-02-22 06:50 am |
N/A 2033-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer |
16,030 | $0 | 51,936 (Direct) |
View |
2023-02-21 Tax Withholding |
2023-02-22 06:49 am |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS Chief Research Officer |
715 | $58.5 | 83,666 (Direct) |
View |
2023-02-21 Option Award |
2023-02-22 06:49 am |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS Chief Research Officer |
23,909 | $0 | 83,666 (Direct) |
View |
2023-02-21 Tax Withholding |
2023-02-22 06:46 am |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
441 | $58.5 | 58,830 (Direct) |
View |
2023-02-21 Option Award |
2023-02-22 06:46 am |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
12,769 | $0 | 58,830 (Direct) |
View |
2023-02-21 Tax Withholding |
2023-02-22 06:46 am |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
825 | $58.5 | 69,552 (Direct) |
View |
2023-02-21 Option Award |
2023-02-22 06:46 am |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
23,909 | $0 | 69,552 (Direct) |
View |
2023-02-21 Tax Withholding |
2023-02-22 06:45 am |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
825 | $58.5 | 77,526 (Direct) |
View |
2023-02-21 Option Award |
2023-02-22 06:45 am |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
23,909 | $0 | 77,526 (Direct) |
View |
2023-02-21 Tax Withholding |
2023-02-22 06:44 am |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
334 | $58.5 | 36,600 (Direct) |
View |
2023-02-21 Option Award |
2023-02-22 06:44 am |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
9,781 | $0 | 36,600 (Direct) |
View |
2023-02-21 Tax Withholding |
2023-02-22 06:44 am |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
1,195 | $58.5 | 1,028,336 (Direct) |
View |
2023-02-21 Option Award |
2023-02-22 06:44 am |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
23,909 | $0 | 1,028,336 (Direct) |
View |
2023-02-21 Tax Withholding |
2023-02-22 06:42 am |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
974 | $58.5 | 150,517 (Direct) |
View |
2023-02-21 Option Award |
2023-02-22 06:42 am |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
28,255 | $0 | 150,517 (Direct) |
View |
2023-02-21 Tax Withholding |
2023-02-22 06:42 am |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
825 | $58.5 | 198,991 (Direct) |
View |
2023-02-21 Option Award |
2023-02-22 06:42 am |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
23,909 | $0 | 198,991 (Direct) |
View |
2023-02-21 Tax Withholding |
2023-02-22 06:40 am |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
1,602 | $58.5 | 1,598,730 (Direct) |
View |
2023-02-21 Option Award |
2023-02-22 06:40 am |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
33,636 | $0 | 1,598,730 (Direct) |
View |
2023-02-21 Tax Withholding |
2023-02-22 06:36 am |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
1,041 | $58.5 | 90,018 (Direct) |
View |
2023-02-21 Option Award |
2023-02-22 06:36 am |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
23,909 | $0 | 90,018 (Direct) |
View |
2023-02-17 Exercise |
2023-02-21 4:22 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $0 | 790,620 (Direct) |
View |
2023-02-17 Exercise |
2023-02-21 4:22 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $2.67 | 790,620 (Direct) |
View |
2023-02-10 Tax Withholding |
2023-02-14 5:29 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
532 | $51.21 | 175,907 (Direct) |
View |
2023-02-10 Tax Withholding |
2023-02-14 5:03 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
782 | $51.21 | 67,150 (Direct) |
View |
2023-02-10 Tax Withholding |
2023-02-14 4:59 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
975 | $51.21 | 123,236 (Direct) |
View |
2023-02-10 Tax Withholding |
2023-02-14 4:44 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS Chief Research Officer |
678 | $51.21 | 60,472 (Direct) |
View |